6
Oct
2026

UGA Biopharma GmbH

Exhibitor at CPHI Milan 2026 stand 12M59, Contract Manufacturing & Services
About Us

UGA Biopharma GmbH is a research and development organization founded in 2009 in Hennigsdorf near Berlin. The company specializes in the development of monoclonal cell lines to produce biologics and biosimilars.
UGA Biopharma supports its customers across the entire development value chain, from cell line development to the development of purification and analytical methods. In addition, it offers ready-to-use (R2U) cell lines for the expression of biosimilar candidates, as well as its proprietary CHO Prime® media and feeds platform for cell culture applications.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Germany
  • Founded:
    2009
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Primary activities
Biopharmaceutical
Contract Research Organisation
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 12M59, Contract Manufacturing & Services

Products Featured at CPHI Milan 2026

  • Ready-to Use CHO cell lines

    Product Ready-to Use CHO cell lines

    UGA Biopharma GmbH offers to their clients Ready-to-use Biosimilar Cell Lines. These are in-house developed CHO cell lines stably expressing different blockbuster biosimilar molecules, that are instantly available for in-licensing. The client profits of direct availability of cell lines banks and prompt ac...
  • Cell Line Development services

    Product Cell Line Development services

    Cell line development services, including molecular cloning, CHO cell line development and lead clone selection, upstream bioprocess optimization, Down stream bioprocessing and analytical characterization of the target molecule. In addition to a detailed documentation in line with regulatory requirement...
  • CHO Prime® Media & Feeds for CHO cell culture

    Product CHO Prime® Media & Feeds for CHO cell culture

    CHO Prime® is a next-generation, GMP-compliant, adaptive media platform designed to maximise productivity while giving you precise control over critical quality attributes, particularly glycosylation. Built for production of biologics and biosimilars, CHO Prime® combines chemically defined, animal componen...